Background and Aims: A bicarbonate dialysate acidified with citrate (CD) has been reported to have local anticoagulant effect and improves biocompatibility. This study examines the effect of CD on dialysis efficiency, coagulation, acid-base status, electrolytes, and inflammation in patients in on-line hemodiafiltration (OL-HDF). Methods: 35 patients in OL-HDF were enrolled in a prospective, cross-over study for a 24-week period and two phases alternating CD and acetate dialysate fluid (AD). Parameters on study were predialysis levels of bicarbonate and ionic calcium, reactive C Protein (CRP), and beta-2 microglobulin (B2MG) and postdialysis levels of activated tromboplastine time, bicarbonate, and ionized calcium. Results: No significant differences in coagulation parameters, pH, and predialysis bicarbonate were found. The postdialysis bicarbonate and postdialysis calcium were lower with CD. Dialysis efficiency was greater with CD. Regarding inflammatory parameters, both CRP and B2MG were lower using CD. Conclusion: The use of CD is safe and effective in OL-HDF, and it improves dialysis efficacy, postdialysis alkalosis, and inflammation.

Keywords:
Acetate-free hemodialysis, Biocompatibility, Chronic inflammation, Citrate, Hemodiafiltration
1.
Ahmad S, Callan R, Cole J, Blagg C: Increased dialyzer reuse with citrate dialysate. Hemodial Int 2005;9:264-267.
2.
Pawlak K, Naumnik B, Brzosko S, Pawlak D, Myśliwiec M: Oxidative stress - a link between endothelial injury, coagulation activation, and atherosclerosis in haemodialysis patients. Am J Nephrol 2004;24:154-161.
3.
Sands JJ, Kotanko P, Segal JH, Ho CH, Usvat L, Young A, Carter M, Sergeyeva O, Korth L, Maunsell E, Zhu Y, Krishnan M, Diaz-Buxo JA: Effects of citrate acid concentrate (citrasate®) on heparin N requirements and hemodialysis adequacy: a multicenter, prospective noninferiority trial. Blood Purif 2012;33:199-204.
4.
Ahmad S, Callan R, Cole JJ, Blagg CR: Dialysate made from dry chemicals using citric acid increases dialysis dose. Am J Kidney Dis 2000;35:493-499.
5.
Kossmann RJ, Gonzales A, Callan R, Ahmad S: Increased efficiency of hemodialysis with citrate dialysate: a prospective controlled study. Clin J Am Soc Nephrol 2009;4:1459-1464.
6.
Grundström G, Christensson A, Alquist M, Nilsson LG, Segelmark M: Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility. BMC Nephrol 2013;14:216.
7.
Guth HJ, Gruska S, Kraatz G: On-line production of ultrapure substitution fluid reduces TNF-alpha- and IL-6 release in patients on hemodiafiltration therapy. Int J Artif Organs 2003;26:181-187.
8.
Canaud B, Wizemann V, Pizzarelli F, Greenwood R, Schultze G, Weber C, Falkenhagen D: Cellular interleukin-1 receptor antagonist production in patients receiving on-line haemodiafiltration therapy. Nephrol Dial Transplant 2001;16:2181-2187.
9.
Carracedo J, Merino A, Nogueras S, Carretero D, Berdud I, Ramirez R, Tetta C, Rodriguez M, Martin-Malo A, Aljama P: On-line hemodiafiltration reduces the proinflammatory CD14+CD16+ monocyte-derived dendritic cells: a prospective, crossover study. J Am Soc Nephrol 2006;17:2315-2321.
10.
Lin CL, Yang CW, Chiang CC, Chang CT, Huang CC: Long-term on-line hemodiafiltration reduces predialysis beta-2-microglobulin levels in chronic hemodialysis patients. Blood Purif 2001;19:301-307.
11.
Lornoy W, Becaus I, Billiouw JM, Sierens L, Van Malderen P, D'Haenens P: On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations. Nephrol Dial Transplant 2000;15(suppl 1):49-54.
12.
Pizzarelli F, Cerrai T, Dattolo P, Ferro G: On-line haemodiafiltration with and without acetate. Nephrol Dial Transplant 2006;21:1648-1651.
13.
Gabutti L, Lucchini B, Marone C, Alberio L, Burnier M: Citrate- vs acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes. BMC Nephrol 2009;10:7.
14.
Matsuyama K, Tomo T, Kadota J: Acetate-free blood purification can impact improved nutritional status in hemodialysis patients. J Artif Organs 2011;14:112-119.
15.
Böhler J, Schollmeyer P, Dressel B, Dobos G, Hörl WH: Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation. J Am Soc Nephrol 1996;7:234-241.
16.
Bos JC, Grooteman MP, Van Houte AJ, Schoorl M, Van Limbeek J, Nubé MJ: Low polymorphonuclear cell degranulation during citrate anticoagulation: a comparison between citrate and heparin dialysis. Nephrol Dial Transplant 1997;12:1387-1393.
17.
Dhondt A, Vanholder R, Tielemans C, Glorieux G, Waterloos MA, De Smet R, Lameire N: Effect of regional citrate anticoagulation on leukopenia, complement activation, and expression of leukocyte surface molecules during hemodialysis with unmodified cellulose membranes. Nephron 2000;85:334-342.
18.
Gabutti L, Ferrari N, Mombelli G, Keller F, Marone C: The favorable effect of regional citrate anticoagulation on interleukin-1beta release is dissociated from both coagulation and complement activation. J Nephrol 2004;17:819-825.
19.
Gritters M, Grooteman MP, Schoorl M, Schoorl M, Bartels PC, Scheffer PG, Teerlink T, Schalkwijk CG, Spreeuwenberg M, Nube MJ: Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis. Nephrol Dial Transplant 2006;21:153-159.
20.
Lowrie EG, Li Z, Ofsthun NJ, Lazarus JM: Evaluating a new method to judge dialysis treatment using online measurements of ionic clearance. Kidney Int 2006;70:211-217.
21.
Maduell F, Ramos R, Palomares I, Martin-Malo A, Molina M, Bustamante J, Pérez-García R, Grassmann A, Merello JI: Impact of targeting Kt instead of Kt/V. Nephrol Dial Transplant 2013;28:2595-2603.
22.
Maduell F, Vera M, Serra N, Collado S, Carrera M, Fernandez A, Arias M, Blasco M, Burgada E, Cases A, Campistol JM: [Kt as control and follow-up of the dose at a hemodialysis unit]. Nefrologia 2008;28:43-47.
23.
Molina Núñez M, Roca Meroño S, de Alarcón Jiménez RM, García Hernández MA, Jimeno Griño C, Alvarez Fernández GM, Navarro Parreño MJ, Pérez Silva FM: [Kt calculation as a quality indicator of haemodialysis adequacy]. Nefrologia 2010;30:331-336.
24.
Aniort J, Petitclerc T, Créput C: Safe use of citric acid-based dialysate and heparin removal in postdilution online hemodiafiltration. Blood Purif 2012;34:336-343.
25.
Panichi V, Fiaccadori E, Rosati A, Fanelli R, Bernabini G, Scatena A, Pizzarelli F: Post-dilution on line haemodiafiltration with citrate dialysate: first clinical experience in chronic dialysis patients. ScientificWorldJournal 2013;2013:703612.
26.
Ledebo I: Acid-base correction and convective dialysis therapies. Nephrol Dial Transplant 2000;15(suppl 2):45-48.
27.
Kuragano T, Kida A, Furuta M, Yahiro M, Kitamura R, Otaki Y, Nonoguchi H, Matsumoto A, Nakanishi T: Effects of acetate-free citrate-containing dialysate on metabolic acidosis, anemia, and malnutrition in hemodialysis patients. Artif Organs 2012;36:282-290.
28.
Maduell F, Moreso F, Pons M, Ramos R, Mora-Macià J, Carreras J, Soler J, Torres F, Campistol JM, Martinez-Castelao A: High-efficiency postdilution online haemodiafiltration reduces all-cause mortality in haemodialysis patients. J Am Soc Nephrol 2013;24:487-497.
29.
Thijssen S, Kossmann RJ, Kruse A, Kotanko P: Clinical evaluation of a model for prediction of end-dialysis systemic ionized calcium concentration in citrate hemodialysis. Blood Purif 2013;35:133-138.
30.
Amore A, Cirina P, Mitola S, Peruzzi L, Bonaudo R, Gianoglio B, Coppo R: Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. J Am Soc Nephrol 1997;9:1431-1436.
31.
Todeschini M, Macconi D, Fernandez NG, Ghilardi M, Anabaya A, Binda E, Morigi M, Cattaneo D, Perticucci E, Remuzzi G, Noris M: Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation. Am J Kidney Dis 2002;40:783-793.
32.
Bryland A, Wieslander A, Carlsson O, Hellmark T, Godaly G: Citrate treatment reduces endothelial death and inflammation under hyperglycaemic conditions. Diab Vasc Dis Res 2012;9:42-51.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.